Iverlast 6 Tablet contains Ivermectin 6 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is indicated for the treatment of strongyloidiasis, onchocerciasis, and other infections caused by susceptible parasites such as certain types of roundworms, lice, and scabies mites. Iverlast 6 Tablet is administered orally, with dosage and duration determined based on the specific parasitic infection and patient factors including weight and clinical response. It is generally well tolerated, but potential side effects may include dizziness, nausea, diarrhea, and mild skin rash. Caution is advised in patients with impaired liver function or those taking concomitant medications that may interact with Ivermectin. It is contraindicated in individuals with known hypersensitivity to Ivermectin or any of the tablet’s excipients. Pregnant and breastfeeding women should use this medication only if clearly needed and under medical supervision. Proper diagnosis and adherence to prescribed dosage are essential to ensure efficacy and minimize adverse effects.